Abstract
Purpose of Review
Congenital heart disease (CHD), the most common of birth defects, can be serious enough to require a lifetime of medical care including multiple surgeries or other interventions.
Recent Findings
Advances in ultrasound technology and a better understanding of the progression of CHDs have made it possible to intervene in utero. This early-stage intervention allows the still plastic cardiovascular system to return to a more normal trajectory thus sparing the newborn from negative consequences to morbidity and mortality.
Summary
Fetal cardiac intervention (FCI) has been successful altering the course of right and left ventricular disease. This bodes well for expanding the use of FCI to lead to better postnatal adaptation and improved long-term function for more children with CHD. However, optimism with success must be tempered with small numbers of procedures performed thus far and current efforts with international registries and multi-centered studies are extremely important to document improved survival and resultant biventricular outcomes.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900.
Moon-Grady AJ, Morris SA, et al. International fetal cardiac intervention registry. J Am Coll Cardiol. 2015;66:387–99.
Tulzer G, Gardiner H. Cardiac interventions in the fetus: potential for right-sided lesions. Fetal interventions in right heart disease. Prog Pediatr Cardiol. 2006;22:79–83.
Eibschitz I, Abinader EG, Klein A, Sharf M. Intrauterine diagnosis and control of fetal ventricular arrhythmia during labor. Am J Obstet Gynecol. 1975;122:597–600.
Gardiner H. Progression of fetal heart disease and rationale for fetal intracardiac interventions. Semin Fetal Neonatal Med. 2005;10:578–85.
Wohlmuth C, Tulzer G, Artz W, Gitter R, Werashnigg D. Maternal aspects of fetal cardiac intervention. Ultrasound Obstet Gynecol. 2014;44:532–7.
Pavlovic M, Acharya G, Huhta JC. Controversies of fetal cardiac intervention. Early Hum Dev. 2008;84(3):149–53.
Mitchell MEIR, Gaynor JW, Wernosky G, Nicolson S, Spray TL. Intermediate outcomes after the Fontan procedure in the current era. J Thorac Cardiovasc Surg. 2006;131:172–80.
AK GNS, Tabbut S, Atz AM, Clabby ML, Cooper DS, Eghtesady P, et al. Interstage mortality after the Norwood procedure; results of the multi-center Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg. 2012;144:896–906.
Williams IASL, Colan SD, Lu M, Stephenson EA, Newburger JW, Gersony WM, et al. Functional state following the Fontan procedure. Cardiol Young. 2009;19:320–30.
Allan LD, Sharland G, Tynan MJ. The natural history of the hypoplastic left heart syndrome. Int J Cardiol. 1989;25:341–3.
Danford DA, Cronican P. Hypoplastic left heart syndrome: progression of left ventricular dilation and dysfunction to left ventricular hypoplasia in utero. Am Heart J. 1992;123:1712–3.
Simpson JM, Sharland GK. Natural history and outcome of aortic stenosis diagnosed prenatally. Heart. 1997;77:205–10.
McCaffrey FM, Sherman FS. Prenatal diagnosis of severe aortic stenosis. Pediatr Cardiol. 1997;18:276–81.
Makikallio KMD, Levine JC, Marx GR, Colan SD, Marshall AC, Lock JE, et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention. Circulation. 2006;113:1401–5.
Selamet Tierney ES, Wald RM, McElhinney DB, Marshall AC, Benson CB, Colan SD, et al. Changes in left heart hemodynamics after technically successful in-utero aortic valvuloplasty. Ultrasound Obstet Gynecol. 2007;30:715–20.
Prosnitz AR, Drogosz M, Marshall AC, Wilkins-Haug LE, Benson CB, Sleeper LA, et al. Early hemodynamic changes after fetal aortic stenosis valvuloplasty predict biventricular circulation at birth. Prenat Diagn. 2018;38:286–92.
McElhinney DB, Marshall AC, Wilkins-Haug LE, Brown DW, Benson CB, Silva V, et al. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome. Circulation. 2009;120:1482–90.
Friedman KG, Sleeper LA, Freud LR, Marshall AC, Godfrey ME, Drogosz M, et al. Improved technical success, postnatal outcome and refined predictors of outcome for fetal aortic valvuloplasty. Ultrasound Obstet Gynecol. 2018;52:212–20.
Freud LR, McElhinney DB, Marshall AC, Marx GR, Friedman KG, del Nido PJ, et al. Fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome: postnatal outcomes of the first 100 patients. Circulation. 2014;130:638–45.
Kovacevic A, Ohman A, Tulzer G, Herberg U, Dangel J, Carvalho JS, et al. Fetal hemodynamic response to aortic valvuloplasty and postnatal outcome: a European multicenter study. Ultrasound Obstet Gynecol. 2018;52:221–9.
Friedman KG, Margossian R, Graham DA, Harrild DM, Emani SM, Wilkins-Haug LE, et al. Postnatal left ventricular diastolic function after fetal aortic valvuloplasty. Am J Cardiol. 2011;108:556–60.
Friedman KG, Freud L, Escobar-Diaz M, Banka P, Emani S, Tworetzky W. Left ventricular remodeling and function in children with biventricular circulation after fetal aortic valvuloplasty. Pediatr Cardiol. 2015;36:1502–9.
Laraja K, Sadhwani A, Tworetzky W, Marshall AC, Gauvreau K, Freud L, et al. Neurodevelopmental outcome in children after fetal cardiac intervention for aortic stenosis with evolving hypoplastic left heart syndrome. J Pediatr. 2017;184:130–6 e4.
Rychik J, Rome JJ, Collins MH, DeCampli WM, Spray TL. The hypoplastic left heart syndrome with intact atrial septum: atrial morphology, pulmonary vascular histopathology and outcome. J Am Coll Cardiol. 1999;34:554–60.
Glatz JA, Tabbutt S, Gaynor JW, Rome JJ, Montenegro L, Spray TL, et al. Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis. Ann Thorac Surg. 2007;84:1633–8.
Szwast A, Tian Z, McCann M, Donaghue D, Rychik J. Vasoreactive response to maternal hyperoxygenation in the fetus with hypoplastic left heart syndrome. Circ Cardiovasc Imaging. 2010;3:172–8.
Marshall AC, Van Der Velde ME, Tworetzky W, et al. Creation of an atrial septal defect in utero for fetuses with hypoplastic left heart syndrome and intact or highly restrictive atrial septum. Circulation. 2004;110:253–8.
Olivieri L, Ratnayaka K, Levy RJ, Berger J, Wessel D, Donofrio M. Hypoplastic left heart syndrome with intact atrial septum sequelae of left atrial hypertension in utero. J Am Coll Cardiol. 2011;57:e369.
Schidlow DN, Freud L, Friedman K, Tworetzky W. Fetal interventions for structural heart disease. Echocardiography. 2017;34:1834–41.
Divanović A, Hor K, Cnota J, Hirsch R, Kinsel-Ziter M, Michelfelder E. Prediction and perinatal management of severely restrictive atrial septum in fetuses with critical left heart obstruction: clinical experience using pulmonary venous Doppler analysis. J Thorac Cardiovasc Surg. 2011;141:988–94.
Kalish BT, Tworetzky W, Benson CB, Wilkins-Haug L, Mizrahi-Arnaud A, McElhinney D, et al. Technical challenges of atrial septal stent placement in fetuses with hypoplastic left heart syndrome and intact atrial septum. Catheter Cardiovasc Interv. 2014;84:77–85.
Marshall A, Levine J, et al. Results of in utero atrial septoplasty in fetuses with hypoplastic left heart syndrome. Prenat Diagn. 2008;28:1023–8.
Chaturvedi RR, Ryan G, Seed M, Van Arsdell G, Jaeggi ET. Fetal stenting of the atrial septum: technique and initial results in cardiac lesions with left atrial hypertension. Int J Cardiol. 2013;168:2029–36.
• Edwards A, Veldman A, et al. A percutaneous fetal cardiac catheterization technique for pulmonary valvuloplasty and valvulotomy in mid-gestation lamb model. Prenatal Diag. 2015;35:74–80 Excellent paper on basic science research for fetal cardiac intervention.
• Fontes-Pedra SRF, Peralta CFA, et al. Fetal interventions for congenital heart disease in Brazil. Pediatric Cardiol. 2014;35:399–405 Large cohort of patients undergoing fetal cardiac intervention.
Gomez-Montes E, Herraiz I, Medoza A, Galindo A. Fetal intervention in right outflow tract obstructive disease: selection of candidates and results. Cardiol Res Pract. 2012;2012:1–8.
Huhta J, Quintero RA, Suh E, Bader R. Advances in fetal cardiac intervention. Curr Opin Pediatr. 2004;16:487–93.
Kohl T. Fetal echocardiography: new grounds to explore during fetal cardiac intervention. Pediatr Cardiol. 2002;23:334–46.
• Tulzer A, Arzt W, Gitter R, Prandstetter C, Grohmann E, Mair R, et al. Immediate effects and outcome of in-utero pulmonary valvuloplasty in fetuses with pulmonary atresia with intact ventricular septum or critical pulmonary stenosis. Ultrasound Obstet Gynecol. 2018;52:230–7 Excellent review of a large cohort of patients undergoing fetal cardiac intervention.
Tulzer G, Arzt W, Franklin RCG, Loughna P, Mair R, Gardiner HM. Fetal pulmonary valvuloplasty for critical pulmonary stenosis or atresia with intact septum. Lancet. 2002;360:1567–8.
Tworetzky W, McElhinney D, Marx GR, Benson CB, Brusseau R, Morash D, et al. In utero valvuloplasty for pulmonary atresia with hypoplastic right ventricle: techniques and outcomes. Pediatrics. 2009;124:e510–8.
Gardiner H, Belmar C, Tulzer G, Barlow A, Pasquini L, Carvalho JS, et al. Morphologic and functional predictors of eventual circulation in the fetus with pulmonary atresia or critical pulmonary stenosis with intact septum. J Am Coll Cardiol. 2008;51:1299–308.
Salvin J, McElhinney D, Colan SD, Gauvreau K, del Nido P, Jenkins KJ, et al. Fetal tricuspid valve size and growth as predictors of outcome in pulmonary atresia with intact ventricular septum. Pediatrics. 2006;118:e415–20.
Roman KS, Fouron JC, Nii M, Smallhorn JF, Chaturvedi R, Jaeggi ET. Determinants of outcome in fetal pulmonary valve stenosis or atresia with intact ventricular septum. Am J Cardiol. 2007;99:699–703.
McElhinney D, Tworetzky W, Lock J. Current status of fetal cardiac intervention. Circulation. 2010;121:1256–63.
Friedman KG, Sleeper LA, Freud LR, Marshall AC, Godfrey ME, Drogosz M, et al. Improved technical success, postnatal outcome and refined predictors of outcome for fetal aortic valvuloplasty. Ultrasound Obstet Gynecol. 2018;52:212–20.
Marshall AC, Tworetzky W, Bergersen L, McElhinney DB, Benson CB, Jennings RW, et al. Aortic valvuloplasty in the fetus: technical characteristics of successful balloon dilation. J Pediatr. 2005;147:535–9.
Mizrahi-Arnaud A, Tworetzky W, Bulich LA, Wilkins-Haug LE, Marshall AC, Benson CB, et al. Pathophysiology, management, and outcomes of fetal hemodynamic instability during prenatal cardiac intervention. Pediatr Res. 2007;62:325–30.
Galindo A, Gomez-Montes E, Gomez O, Bennasar M, Crispi F, Herraiz I, et al. Fetal aortic valvuloplasty: experience and results of two tertiary centers in Spain. Fetal Diagn Ther. 2017;42:262–70.
Wohlmuth C, Tulzer G, Arzt W, Gitter R, Wertaschnigg D. Maternal aspects of fetal cardiac intervention. Ultrasound Obstet Gynecol. 2014;44:532–7.
Acknowledgments
We would like to acknowledge the following team members, without them this procedure would not be possible at our institution:
“Mom and Dad”
The Congenital Heart Collaborative Leadership
Aimee Armstrong – Interventionalist
Martin Bocks – Interventionalist
Jim Strainic – Fetal Cardiologist
Karen Texter – Fetal Cardiologist
Ellie Ragsdale – MFM
Lora Levin – OB Anesthesia
Mike Lilly – OB Anesthesia
Tiffanie McCourt – Fetal coordinator
Liz Ruzga – OB patient navigator
Katie O’Neill – cath lab NP
Stacey Carey – cath lab RN
Bernadette Richards – sonographer
Monica Mielcarek – sonographer
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Armstrong reports personal fees from Medtronic Inc.; grants from Siemens Medical Solutions USA, Inc.; grants and personal fees from Edwards Lifesciences; personal fees from Abbott; and personal fees from the Intersocietal Accreditation Commission. Dr. Strainic declares no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Cardiology
Rights and permissions
About this article
Cite this article
Strainic, J., Armstrong, A. Fetal Cardiac Intervention: a Review of the Current Literature. Curr Pediatr Rep 8, 1–9 (2020). https://doi.org/10.1007/s40124-020-00209-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40124-020-00209-6